Skip to main content
Log in

Hypoglycemia after exposure of diclofenac medication

  • Brief report
  • Published:
Endocrine Aims and scope Submit manuscript

Abstract

Context

Diclofenac is commonly used as pain relief. Hypoglycemia has rarely been reported due to aspirin and indomethacin use but not of any other nonsteroidal anti-inflammatory drugs.

Case report

A 69-years old endocrinologist participated as a control in a glucagon-like peptide-1 (GLP-1) study. He decreased his plasma glucose to 1.8 mmol/L and developed full-blown hypoglycemic symptoms during an oral glucose tolerance test (OGTT). He had taken a 50 mg diclofenac tablet at 10 pm the evening before for a harmless muscle stretch in the lower back. Apart from well-controlled hypothyroidism he was healthy. During medical school he often had reactive hypoglycemia which came after intake of a carbohydrate rich but otherwise poor breakfast followed by bicycling. However, he had never experienced problems later in life after more decent meals containing slower absorbable carbohydrates. A 3-day continuous glucose monitoring (CGM) was performed three weeks after the OGTT test. A glucose value of 3.1 mmol/L was registered on the third CGM day in the afternoon after intake of 500 mg aspirin in the early morning the same day. Otherwise, all values were normal. A second OGGT where no medications apart from levothyroxine had been taken during at least a 2-week period adjacent was normal. Detailed analyses of the OGTTs showed that the GLP-1 levels before the test were higher after diclofenac exposure while the insulin levels increased after the glucose challenge which suggesting uncoupling.

Conclusion

With this case report we would like to draw attention to that diclofenac may cause hypoglycemia.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1

References

  1. R.W. Chang, D.M. Tompkins, S.M. Cohn, Are NSAIDs Safe? Assessing the risk-benefit profile of nonsteroidal anti-inflammatory drug use in postoperative pain management. Am. Surg. 87(6), 872–879 (2021)

    Article  PubMed  Google Scholar 

  2. A.R. Meloni, M.B. DeYoung, C. Lowe, D.G. Parkes, GLP-1 receptor activated insulin secretion from pancreatic beta-cells: mechanism and glucose dependence. Diabetes Obes. Metab. 15(1), 15–27 (2013)

    Article  CAS  PubMed  Google Scholar 

  3. C. Douillard, A. Jannin, M.C. Vantyghem, Rare causes of hypoglycemia in adults. Ann. Endocrinol. (Paris) 81(2-3), 110–117 (2020)

    Article  PubMed  Google Scholar 

  4. M.H. Murad, F. Coto-Yglesias, A.T. Wang, N. Sheidaee, R.J. Mullan, M.B. Elamin et al. Clinical review: Drug-induced hypoglycemia: a systematic review. J. Clin. Endocrinol. Metab. 94(3), 741–745 (2009)

    Article  CAS  PubMed  Google Scholar 

  5. M.K. Pandit, J. Burke, A.B. Gustafson, A. Minocha, A.N. Peiris, Drug-induced disorders of glucose tolerance. Ann. Intern Med. 118(7), 529–539 (1993)

    Article  CAS  PubMed  Google Scholar 

  6. P.R. Bratusch-Marrain, H. Vierhapper, M. Komjati, W.K. Waldhausl, Acetyl-salicylic acid impairs insulin-mediated glucose utilization and reduces insulin clearance in healthy and non-insulin-dependent diabetic man. Diabetologia 28(9), 671–676 (1985)

    Article  CAS  PubMed  Google Scholar 

  7. H. Vierhapper, P. Bratusch-Marrain, W. Waldhausl, P. Nowotny, S. Panzer, Increased secretion of insulin but unchanged secretion of growth hormone in hyperglycaemic type II diabetics treated with acetyl-salicylic acid. Clin. Endocrinol. 18(6), 613–619 (1983)

    Article  CAS  Google Scholar 

  8. R.S. Hundal, K.F. Petersen, A.B. Mayerson, P.S. Randhawa, S. Inzucchi, S.E. Shoelson et al. Mechanism by which high-dose aspirin improves glucose metabolism in type 2 diabetes. J. Clin. Invest. 109(10), 1321–1326 (2002)

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  9. P.A. Todd, E.M. Sorkin, Diclofenac sodium. A reappraisal of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy. Drugs 35(3), 244–285 (1988)

    Article  CAS  PubMed  Google Scholar 

  10. R.L. Rushworth, D.J. Torpy, H. Falhammar, Adrenal crisis. N. Engl. J. Med. 381(9), 852–61. (2019)

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Henrik Falhammar.

Ethics declarations

Conflict of interest

The authors declare no competing interests.

Additional information

Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Falhammar, H., Törring, O., Larsson, M. et al. Hypoglycemia after exposure of diclofenac medication. Endocrine 79, 455–458 (2023). https://doi.org/10.1007/s12020-022-03252-z

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12020-022-03252-z

Keywords

Navigation